Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Boston Scientific Corp

BSX ✓ COMPLIANT ☆ Track — members

NYSE · Healthcare · Advanced Medical Equipment & Technology ·

USA Large Cap Analyst: BUY

Last Close

$44.98

▼ -5.90%

Market Cap $65.19B · Vol 5.53M

Key Metrics

P/E Ratio

18.24

FWD: 13.32

Market Cap

$65.19B

Large Cap

Div Yield

N/A

EPS Growth

+7.94%

YoY

RSI (14)

34.59

Momentum

Beta

0.57

vs Market

52W High

$109.50

58.92% below

52W Low

$42.20

6.59% above

Volume

5.53M

Avg 4.67M

P/B

5.84

Price-to-book

ROE

19.37%

Return on equity

Free Float

99.62%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Boston Scientific Corp (BSX) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does BSX pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-6.87%

-8.78%

-7.64%

-36.96%

YTD

-52.83%

-58.41%

-16.50%

-1.16%

Financials & Valuation

TTM · Annual

Total Revenue	$20.07B
Net Income	$2.89B
Revenue Growth (YoY)	+7.53%
Gross Margin	64.54%
Operating Margin	22.35%
Net Profit Margin	14.41%
ROE	19.37%
ROA · ROIC	8.15% · 9.31%

P/E Ratio	18.24
Forward P/E (FY1)	13.32
PEG Ratio	0.89
P/S	7.10
P/B	5.84
P/FCF	41.86
EPS Growth	+7.94%
Outstanding Shares	1.45B

Technical Indicators

50-Day SMA	$46.90
200-Day SMA	$66.49
RSI (14)	34.59
Beta	0.57
52-Week High	$109.50
52-Week Low	$42.20

Volume Today	5.53M
Avg Daily Volume (30D)	4.67M
Relative Volume	1.18x
Volatility (10D)	43.79
Volatility (30D)	38.77
Free Float	99.62%

Analyst Consensus

BUY

Current Price $44.98

Mean Target $65.38

52W Low$42.20 52W High$109.50

Current

Target

$42.20 $109.50

Current Analyst target

+45.34% upside potential · 34 analysts

Identifiers

ExchangeNYSE

FIGIBBG001S63L94

ISINUS1011371077

CountryUnited States of America

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateOct 28, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.75% DHR Danaher Corp -1.17% ISRG Intuitive Surgical Inc -4.51% SHL.DE Siemens Healthineers AG +0.98% EW Edwards Lifesciences Corp -3.54%

Company Profile

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology and vascular therapies (ICVT), watchman, cardiac rhythm management, and electrophysiology.